Universe Pharmaceuticals INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
Gang Lai, CEO and Chairman of Universe Pharmaceuticals, has increased his beneficial ownership to 13.58% through direct holdings and a controlled entity, following an equity grant.